BRIDGEBIO PHARMA INC. - COMMON STOCK
25.23
04-October-24 14:59:59
15 minutes delayed
Stocks
-0.40
-1.56%
Today's range
25.12 - 26.05
ISIN
N/A
Source
NASDAQ
-
03 Jun 2024 15:01:00 By Nasdaq GlobeNewswire
-
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
15 May 2024 06:30:00 By Nasdaq GlobeNewswire
-
14 May 2024 06:30:00 By Nasdaq GlobeNewswire
-
13 May 2024 06:30:00 By Nasdaq GlobeNewswire
-
BridgeBio Pharma Reports First Quarter 2024 Financial Results and Business Update
02 May 2024 06:30:00 By Nasdaq GlobeNewswire
-
02 May 2024 06:00:00 By Nasdaq GlobeNewswire
-
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
10 Apr 2024 06:30:00 By Nasdaq GlobeNewswire
-
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
20 Mar 2024 06:30:00 By Nasdaq GlobeNewswire
-
BridgeBio Pharma Announces Pricing of Public Offering of Common Stock
05 Mar 2024 22:53:56 By Nasdaq GlobeNewswire
-
BridgeBio Pharma Announces Proposed Public Offering of Common Stock
04 Mar 2024 15:17:36 By Nasdaq GlobeNewswire
-
BridgeBio Pharma and Bayer Announce European Licensing Agreement for Acoramidis in ATTR-CM
04 Mar 2024 01:30:00 By Nasdaq GlobeNewswire
-
BridgeBio Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Business Update
22 Feb 2024 06:30:00 By Nasdaq GlobeNewswire
-
07 Feb 2024 06:34:22 By Nasdaq GlobeNewswire
-
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
06 Feb 2024 06:30:00 By Nasdaq GlobeNewswire
-
18 Jan 2024 06:00:00 By Nasdaq GlobeNewswire